Mesothelioma Cancer Centers
Affiliated with the University of Vermont, the Vermont Regional Cancer Center is a comprehensive clinical and research cancer facility, founded in 1974. Committed to research, prevention, treatment, and cancer-related public education, this facility has made significant contributions to cancer study and their findings have resulted in a better understanding of the disease. These contributions include the finding of links between cancer and high cholesterol, the discovery of inherited risk factors for breast cancer, and the pioneering of a biopsy that has put a new spin on treatment for several forms of cancer.
The Vermont Regional Cancer Center works together with Fletcher Allen Healthcare to provide clinical services for those suffering from all types of cancer like mesothelioma cancer (pericardial mesothelioma and peritoneal mesothelioma). The utilization of the team approach allows patients to see all the doctors involved in their care on one day, in one place. The team, which consists of an oncologic specialist in the patient's type of cancer as well as radiologists, surgeons, and other medical professionals, develops a specific like treatment plan for each Vermont Cancer Center patient and the team continues to meet to revise the plan as needed.
In addition to cutting-edge treatments for cancer (like mesothelioma), including minimally-invasive surgery, the latest in chemotherapy drugs like Carboplatin, Gemcitabine, and Alimta®, and the finest in radiation technologies, Vermont Regional provides a chance to participate in a host of clinical trials, at the recommendation of the patient's medical team. As a matter of fact, this facility is the major resource for clinical trials in Vermont and surrounding areas.
In addition, the hospital offers pain management services, palliative/end-of-life care, support groups, transportation and lodging assistance, individual psychological counseling, and a one-on-one mentor service that pairs cancer patients with others like them who are fighting or have fought the same kind of cancer.
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Vermont Regional Cancer Center